Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 501 – 520 of 3231

COVID-19 Vaccines

https://clinicalinfo.hiv.gov/drugs/covid-19-vaccines/patient

Vacunas contra la COVID-19

https://clinicalinfo.hiv.gov/drugs/covid-19-vaccines/patient

COVID-19 Vaccines

https://clinicalinfo.hiv.gov/drugs/covid-19-vaccines/fda-labels

Guidance for People With HIV Displaced by Los Angeles Wildfires

https://clinicalinfo.hiv.gov/news/guidance-people-hiv-displaced-los-angeles-wildfires

Guía para personas con VIH desplazadas por desastres

https://clinicalinfo.hiv.gov/news/guidance-people-hiv-displaced-los-angeles-wildfires

Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/arv-dosing-renal-hepatic-insufficiency

Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-6

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-6

Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-1

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Niños con y Expuestos al VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-children-and-exposed-hiv-1

Update to the Perinatal HIV Clinical Guideline

https://clinicalinfo.hiv.gov/news/update-perinatal-hiv-clinical-guideline

Actualizaciones a las Guías Clínicas sobre el VIH Perinatal

https://clinicalinfo.hiv.gov/news/update-perinatal-hiv-clinical-guideline

Appendix B: Panel Roster and Financial Disclosures

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/panel-roster

Efavirenz / Lamivudine / Tenofovir Disoproxil Fumarate

https://clinicalinfo.hiv.gov/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/patient

Efavirenz / Lamivudina / Fumarato de disoproxilo de tenofovir

https://clinicalinfo.hiv.gov/drugs/efavirenz-lamivudine-tenofovir-disoproxil-fumarate/patient

Cardiovascular and Metabolic Complications in People With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-and-metabolic

Immune Activation and Inflammation Among People With HIV Receiving Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/immune-activation-inflammation

Update to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-7

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/update-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-7

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/cardiovascular-metabolic-complications-introduction